Q2 2016 Holdings
Filed 2016-07-28 | 10 holdings | $93.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $26.9K | 1,924,151 | 28.9% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $14.8K | 1,875,524 | 15.9% |
| Trevena, Inc. | Common Stock | 89532E109 | $14.3K | 2,270,319 | 15.4% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $8.1K | 1,968,606 | 8.7% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $7.1K | 3,607,996 | 7.6% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $7.0K | 3,287,529 | 7.5% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $5.1K | 1,827,992 | 5.5% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $4.9K | 998,713 | 5.3% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $4.2K | 2,473,186 | 4.5% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $789 | 2,018,253 | 0.8% |